How can pharmaceutical and MedTech companies protect their products, data, systems, and patients in an environment where cyber threats are becoming more frequent, more sophisticated, and more operationally disruptive? Cybersecurity is no longer just an IT concern. In the pharmaceutical and medical technology industries, it has become a strategic and regulatory priority that directly affects product integrity, business continuity, patient safety, data protection, and market trust. In highly interconnected environments shaped by digital health platforms, connected medical devices, cloud-based quality systems, manufacturing automation, and global third-party networks, weaknesses in cybersecurity can result in data breaches, production interruptions, regulatory exposure, product vulnerabilities, financial loss, and lasting reputational harm. In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, provides an in-depth analysis of the growing role of cybersecurity across the pharmaceutical and MedTech sectors. The discussion explores how cybersecurity is no longer limited to technical infrastructure, but must be embedded into governance, regulatory strategy, risk management, supplier oversight, and lifecycle product compliance. You will gain a clearer understanding of: How cybersecurity failures can directly impact patient safety, product performance, and regulatory compliance;Why digital health systems, connected devices, and automated environments create new categories of operational and legal risk;The importance of integrating cybersecurity into quality systems, supplier management, and lifecycle governance;Why cybersecurity readiness is becoming essential for market access, regulatory credibility, and long-term business sustainability. In industries where products, systems, and data are closely linked to human health, cybersecurity incidents are not merely technical events, they can become regulatory, financial, clinical, and ethical problems. As digitalization continues to expand across pharmaceutical and MedTech operations, companies must ensure that innovation is supported by strong cybersecurity governance, clear accountability, and resilient control structures. Tune in to understand how effective cybersecurity strategies can help pharmaceutical and MedTech companies protect critical operations, maintain compliance, secure patient and business data, and strengthen trust in an increasingly digital and highly regulated global market. Learn more at: https://www.els-solutions.com/ This episode was recorded in 2026. Some information discussed may have been updated since the recording. The podcast was developed based on multiple bibliographic sources. The views expressed reflect the professional experience of ELS members and the referenced materials consulted.
